Flok Health raises $12.5m to scale the world’s first AI clinician

Healthtech

Posted
June 3 2026

Flok Health, the world’s first AI-operated physiotherapy clinic, has raised $12.5m in an oversubscribed Series A round led by AlbionVC, with participation from existing backers Eka VC and Form Ventures, as well as new investors Mercia Ventures.

Flok Health’s pioneering clinic is the first and only AI platform in Europe to deliver entire healthcare pathways autonomously without requiring human oversight. The tech is currently available to millions of NHS patients across the UK, offering on-demand appointments for back pain with zero waitlist, via a simple mobile app.

Created by former medic and athlete, Finn Stevenson, technologist Ric da Silva, and their team of physiotherapy and AI experts, the digital clinic manipulates real footage of a human physiotherapist to simulate the experience of a live video call appointment that responds in real-time to what a patient is saying and doing.

Flok is the first and only digital MSK service to be approved as a healthcare provider by the UK’s Care Quality Commission, and the first AI system in Europe to gain Class IIa medical device certification for autonomous delivery of full care pathways. This means it can autonomously diagnostically triage, treat, and discharge patients on behalf of the NHS, without human intervention or oversight.

Having halved waiting lists and delivered significant time and resource savings during a series of successful NHS rollouts, the service is now available to more than 2.4 million patients across eleven areas of the NHS. During a recent NHS rollout in England, >80% of patients said the AI clinic was “as good or better than” traditional in-person physio. At the same NHS Trust, the AI pathway saved an average of 856 hours of clinical time per month, enabling clinicians to see more patients with complex cases that required in-person treatment.

Finn Stevenson, Co-founder and CEO at Flok Health, comments: “The most fundamental problem in healthcare today is supply-demand mismatch. Billions of people around the world suffer unnecessarily from treatable conditions, and it’s just never going to be possible for traditional clinicians to solve this one patient at a time. AI is a generational opportunity to close that supply-demand gap and ensure that anyone, anywhere, can get the best possible care whenever they need it. We’re particularly proud to already be scaling our AI MSK clinic in the NHS, and seeing incredible results for patients and services. This new funding will allow us to more rapidly scale our existing back pain service, and to expand the scope of our AI-operated clinic to fully manage new high volume clinical pathways, and new international markets.”

The AI clinic has been exclusively available to patients suffering with back pain to-date. Flok will use the new funding to accelerate scaling its existing back pain service across the UK, while also expanding its clinical and geographical scope. Specifically, the AI technology is currently being trained in other high volume care pathways including hip and knee pain, and women’s pelvic health conditions – with all three of these new services due to launch in the UK this year. Flok’s AI physiotherapist will then be capable of fully managing conditions that affect >20m people every year in the UK, and represent some of the highest demand services in the NHS.

“The supply-demand gap in healthcare is one of the defining challenges of our time. There are over 390,000 sitting on waiting lists in England for MSK conditions alone that are entirely treatable. What Finn, Ric and the team have done is demonstrate, with real patients in a real health system, that it’s possible to deliver entire care pathways autonomously, at scale, without compromising on outcomes. They’ve navigated an extraordinarily complex regulatory environment, earned the trust of NHS partners, and built something that meets patients where they are, removing the practical barriers that often exclude the most vulnerable. That combination of clinical rigour, operational execution and patient impact is rare. MSK is where they’ve proven the model, but the opportunity ahead is far bigger. Having seen how this team operates, we have real confidence in their ability to deliver it.”
Leigh Brody, Investor at AlbionVC

Low back pain is the leading cause of disability worldwide, and more than 30 million work days are lost to musculoskeletal (MSK) conditions every year in the UK. Faced with soaring demand, overstretched and understaffed clinical teams are struggling to provide prompt and effective treatment to those who need it, leaving over 390,000 patients on waiting lists for MSK care in England alone. Flok is helping the NHS overcome these challenges, giving patients immediate access to world-class care, freeing up traditional face-to-face capacity for more complex cases, and creating substantial capacity and cost savings for the NHS.